Zenas BioPharma, Inc. Common Stock (ZBIO) — Working Capital to Net Assets Ratio
Zenas BioPharma, Inc. Common Stock (ZBIO) has a Working Capital to Net Assets ratio of 119.2% as of December 2025. Working capital of $288.52 Million (current assets of $351.17 Million minus current liabilities of $62.65 Million) is measured against net assets of $242.14 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See ZBIO net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Zenas BioPharma, Inc. Common Stock Working Capital to Net Assets (2022–2025)
This chart shows how Zenas BioPharma, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 119.2%, reflecting working capital of $288.52 Million against net assets of $242.14 Million USD. Check Zenas BioPharma, Inc. Common Stock (ZBIO) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Zenas BioPharma, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Zenas BioPharma, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Zenas BioPharma, Inc. Common Stock (ZBIO) market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 119.2% | $288.52 Million | $242.14 Million | $351.17 Million | $62.65 Million | ▲ +23.6 pp |
| 2024 | 95.6% | $298.63 Million | $312.46 Million | $355.92 Million | $57.29 Million | ▲ +111.8 pp |
| 2023 | -16.2% | $36.55 Million | $-225.72 Million | $59.80 Million | $23.26 Million | ▲ +5.9 pp |
| 2022 | -22.1% | $42.48 Million | $-192.29 Million | $68.44 Million | $25.97 Million | — |